Pharmaline, a Lebanese pharmaceutical company established in 1987, is dedicated to improving the lives of men, women, and children throughout the region. Ranked among the top 15 pharmaceutical companies in Lebanon by IMS, Pharmaline is a trusted licensee of multinational and regional companies such as Abbott, Glaxo SmithKline, Novartis, and Sandoz. We offer a wide range of branded generics, manufactured at our state-of-the-art facility just north of Beirut.

Our commitment to quality is evidenced by our adherence to Current Good Manufacturing Practices (cGMP) and our ISO 14001 certifications for Environmental Management System. With a professional marketing and sales force, we export our products to countries in the Middle East, GCC, North Africa, Russia, and Europe. Furthermore, we prioritize research and development, collaborating with reputable institutions to develop differentiated products.

Pharmaline's history dates back to 1936, and since then, we have grown into an internationally recognized pharmaceutical company known for quality standards and an extensive portfolio. Our mission is to continuously produce high-quality and affordable generic medicines to improve the well-being of individuals. As industry leaders, we strive to provide excellence in products and service to patients, healthcare professionals, and partners.

To achieve this, we focus on being solution providers, acquiring licenses both locally and internationally, maintaining competitiveness, and spearheading research and development efforts. Pharmaline's manufacturing facilities operate under cGMP controlled and monitored environments, employing skilled staff and state-of-the-art machinery. Our Solid Form, Semi Solid, and Liquid Form divisions produce a range of pharmaceutical products, ensuring high-quality manufacturing practices.

Our commitment to quality is reinforced by our dedicated quality assurance division, and our warehousing operates under strict compliance with the First Expiry First Out (FEFO) system. Pharmaline, part of the Malia Group, is committed to its vision of being a leader in the pharmaceutical industry, continuously improving and expanding our reach to provide innovative and accessible healthcare solutions